[Mar-2026] Infection Control CIC Exam Practice Test Questions Dumps Bundle! [Q137-Q156]

Share

[Mar-2026] Infection Control CIC Exam Practice Test Questions Dumps Bundle!

2026 Updated CIC PDF for the CIC Tests Free Updated Today!

NEW QUESTION # 137
An infection preventionist (IP) encounters a surgeon at the nurse's station who loudly disagrees with the IP's surgical site infection findings. The IP's BEST response is to:

  • A. Report the surgeon to the chief of staff.
  • B. Ask the surgeon to change their tone and leave the nurses' station if they refuse.
  • C. Calmly explain that the findings are credible.
  • D. Ask the surgeon to speak in a more private setting to review their concerns.

Answer: D

Explanation:
The scenario involves a conflict between an infection preventionist (IP) and a surgeon regarding surgical site infection (SSI) findings, occurring in a public setting (the nurse's station). The IP's response must align with professional communication standards, infection control priorities, and the principles of collaboration and conflict resolution as emphasized by the Certification Board of Infection Control and Epidemiology (CBIC).
The "best" response should de-escalate the situation, maintain professionalism, and facilitate a constructive dialogue. Let's evaluate each option:
* A. Report the surgeon to the chief of staff: Reporting the surgeon to the chief of staff might be considered if the behavior escalates or violates policy (e.g., harassment or disruption), but it is an escalation that should be a last resort. This action does not address the immediate disagreement about the SSI findings or attempt to resolve the issue collaboratively. It could also strain professional relationships and is not the best initial response, as it bypasses direct communication.
* B. Calmly explain that the findings are credible: Explaining the credibility of the findings is important and demonstrates the IP's confidence in their work, which is based on evidence-based infection control practices. However, doing so in a public setting like the nurse's station, especially with a loud disagreement, may not be effective. The surgeon may feel challenged or defensive, potentially worsening the situation. While this response has merit, it lacks consideration of the setting and the need for privacy to discuss sensitive data.
* C. Ask the surgeon to speak in a more private setting to review their concerns: This response is the most appropriate as it addresses the immediate need to de-escalate the public confrontation and move the discussion to a private setting. It shows respect for the surgeon's concerns, maintains professionalism, and allows the IP to review the SSI findings (e.g., data collection methods, definitions, or surveillance techniques) in a controlled environment. This aligns with CBIC's emphasis on effective communication and collaboration with healthcare teams, as well as the need to protect patient confidentiality and maintain a professional atmosphere. It also provides an opportunity to educate the surgeon on the evidence behind the findings, which is a key IP role.
* D. Ask the surgeon to change their tone and leave the nurses' station if they refuse: Requesting a change in tone is reasonable given the loud disagreement, but demanding the surgeon leave if they refuse is confrontational and risks escalating the conflict. This approach could damage the working relationship and does not address the underlying disagreement about the SSI findings. While maintaining a respectful environment is important, this response prioritizes control over collaboration and is less constructive than seeking a private discussion.
The best response is C, as it promotes a professional, collaborative approach by moving the conversation to a private setting. This allows the IP to address the surgeon's concerns, explain the SSI surveillance methodology (e.g., NHSN definitions or CBIC guidelines), and maintain a positive working relationship, which is critical for effective infection prevention programs. This strategy reflects CBIC's focus on leadership, communication, and teamwork in healthcare settings.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain V:
Management and Communication, which stresses effective interpersonal communication and conflict resolution.
CBIC Examination Content Outline, Domain V: Leadership and Program Management, which includes collaborating with healthcare personnel and addressing disagreements professionally.
CDC Guidelines for SSI Surveillance (2023), which emphasize the importance of clear communication of findings to healthcare teams.


NEW QUESTION # 138
Essential knowledge, behaviors, and skills that an individual should possess and demonstrate to practice in a specific discipline defines which of the following?

  • A. Certification
  • B. Training
  • C. Knowledge
  • D. Competence

Answer: D

Explanation:
The correct answer is B, "Competence," as it defines the essential knowledge, behaviors, and skills that an individual should possess and demonstrate to practice in a specific discipline. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, competence encompasses the integrated application of knowledge, skills, and behaviors required to perform effectively in a professional role, such as infection prevention and control. Competence goes beyond mere knowledge or training by including the ability to apply these attributes in real-world scenarios, ensuring safe and effective practice (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.3 - Assess competence of healthcare personnel). This holistic definition is critical in healthcare settings, where demonstrated competence-through actions like proper hand hygiene or outbreak management-directly impacts patient safety and infection prevention outcomes.
Option A (certification) refers to a formal recognition or credential (e.g., CIC certification) that validates an individual's qualifications, but it is an outcome or process rather than the definition of the underlying abilities.
Option C (knowledge) represents the theoretical understanding or factual basis of a discipline, which is a component of competence but not the full scope that includes behaviors and skills. Option D (training) involves the education or instruction provided to develop skills and knowledge, serving as a means to achieve competence rather than defining it.
The focus on competence aligns with CBIC's emphasis on ensuring that healthcare personnel are equipped to meet the demands of infection prevention through a combination of education, practice, and evaluation (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs). This definition supports the development of professionals who can adapt and perform effectively in dynamic healthcare environments.
References: CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competencies 4.2 - Evaluate the effectiveness of educational programs, 4.3 - Assess competence of healthcare personnel.


NEW QUESTION # 139
The appropriate method to obtain cultures for the diagnosis of catheter-associated urinary tract infections (CAUTI) is:

  • A. Aseptic technique via the collection port
  • B. Aseptic technique via the drainage port of the collection bag
  • C. Removal with culture of the urinary catheter tip
  • D. Disconnection of the catheter from the drainage tubing

Answer: A

Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly states that the correct and recommended method for obtaining urine cultures in patients with an indwelling urinary catheter is to collect the specimen using aseptic technique from the catheter's designated sampling (collection) port. This method minimizes the risk of contamination and provides the most accurate reflection of organisms present in the urinary tract.
Urine collected from the sampling port is obtained after disinfecting the port and aspirating urine with a sterile syringe. This approach maintains the integrity of the closed drainage system and reduces the introduction of microorganisms. Accurate culture collection is essential for correct diagnosis of catheter-associated urinary tract infection (CAUTI) and for distinguishing true infection from colonization or contamination.
Option B is incorrect because culturing the catheter tip is not recommended for diagnosing CAUTI; it does not reliably represent urinary tract pathogens and may reflect biofilm colonization. Option C is inappropriate because disconnecting the catheter from the drainage tubing breaks the closed system and increases infection risk. Option D is incorrect because urine from the drainage bag is often contaminated and does not accurately represent bladder urine.
For CIC exam preparation, it is critical to recognize that aseptic aspiration from the catheter sampling port is the standard of care for urine culture collection in catheterized patients and is a core infection prevention principle related to CAUTI surveillance and diagnosis.


NEW QUESTION # 140
The rate of catheter-associated urinary tract infections (CAUTIs) has decreased following recent practice changes. To present these results to the Quality Committee, the infection preventionist should use:

  • A. An affinity diagram.
  • B. A run chart.
  • C. A root cause analysis.
  • D. A fishbone diagram.

Answer: B

Explanation:
To communicate that CAUTI rates decreased after practice changes, the best tool is a run chart, which displays a measure over time and helps determine whether observed changes represent real improvement rather than random variation. The Institute for Healthcare Improvement (IHI) describes run charts as graphs of data over time and emphasizes that improvement and sustainability are demonstrated by observing patterns and shifts over time.
Run charts are especially appropriate for infection prevention metrics because they allow a Quality Committee to see: (1) the baseline period before interventions, (2) the timing of practice changes, and (3) whether there is a sustained downward trend or "shift" in CAUTI rates. Patient safety measurement guidance likewise notes that run charts are a standard quality tool to display trends in patient-safety measures over time and evaluate whether process changes are leading to improvement.
By contrast, an affinity diagram organizes ideas/themes, and fishbone diagrams and root cause analyses are primarily for analyzing causes of a problem-not for clearly presenting a time-based improvement result to leadership. A run chart is therefore the most appropriate communication method.


NEW QUESTION # 141
An infection preventionist is asked to recommend a product for disinfection of bronchoscopes. Which of the following agents would be appropriate?

  • A. Iodophor
  • B. Peracetic acid
  • C. Phenolic
  • D. Alcohol

Answer: B

Explanation:
The correct answer is D, "Peracetic acid," as this agent is appropriate for the disinfection of bronchoscopes.
According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, bronchoscopes are semi-critical devices that require high-level disinfection (HLD) to eliminate all microorganisms except high levels of bacterial spores, as they come into contact with mucous membranes but not sterile tissues. Peracetic acid is recognized by the Centers for Disease Control and Prevention (CDC) and the Association for the Advancement of Medical Instrumentation (AAMI) as an effective high-level disinfectant for endoscopes, including bronchoscopes, due to its broad-spectrum antimicrobial activity, rapid action, and compatibility with the delicate materials (e.g., optics and channels) of these devices (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). It is commonly used in automated endoscope reprocessors, ensuring thorough disinfection when combined with proper cleaning and rinsing protocols.
Option A (iodophor) is typically used for intermediate-level disinfection and skin antisepsis, but it is not sufficient for high-level disinfection of bronchoscopes unless specifically formulated and validated for this purpose, which is uncommon. Option B (alcohol) is effective against some pathogens but evaporates quickly, fails to penetrate organic material, and is not recommended for HLD of endoscopes due to potential damage to internal components and inadequate sporicidal activity. Option C (phenolic) is suitable for surface disinfection but lacks the efficacy required for high-level disinfection of semi-critical devices like bronchoscopes, as it does not reliably eliminate all microbial threats, including mycobacteria.
The selection of peracetic acid aligns with CBIC's emphasis on evidence-based reprocessing practices to prevent healthcare-associated infections (HAIs) associated with endoscope use (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols). This choice ensures patient safety by adhering to manufacturer and regulatory guidelines, such as those in AAMI ST91 (AAMI ST91:2015, Flexible and semi-rigid endoscope processing in health care facilities).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 - Ensure safe reprocessing of medical equipment, 3.4 - Implement environmental cleaning and disinfection protocols. AAMI ST91:2015, Flexible and semi-rigid endoscope processing in health care facilities. CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities, 2019.


NEW QUESTION # 142
Which of the following individuals should be excluded from receiving live attenuated influenza virus?

  • A. Healthy persons aged 2 to 49
  • B. Persons with allergies to chicken feathers
  • C. Pregnant persons
  • D. Persons simultaneously receiving an inactivated vaccine

Answer: C

Explanation:
The correct answer is A, "Pregnant persons," as they should be excluded from receiving the live attenuated influenza virus (LAIV) vaccine. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), the LAIV, commonly known as the nasal spray flu vaccine, contains a live attenuated form of the influenza virus. This vaccine is contraindicated in pregnant individuals due to the theoretical risk of the attenuated virus replicating and potentially harming the fetus, despite limited evidence of adverse outcomes (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents).
Pregnant persons are instead recommended to receive the inactivated influenza vaccine (IIV), which is considered safe during pregnancy.
Option B (healthy persons aged 2 to 49) is incorrect because this group is generally eligible to receive LAIV, provided they have no other contraindications, as the vaccine is approved for healthy, non-pregnant individuals in this age range (CDC Immunization Schedules, 2024). Option C (persons with allergies to chicken feathers) is not a contraindication for LAIV; the vaccine is produced in eggs, and while egg allergy was historically a concern, current guidelines indicate that LAIV can be administered to persons with egg allergies if they can tolerate egg in their diet, with precautions managed by healthcare providers. Option D (persons simultaneously receiving an inactivated vaccine) is also incorrect, as LAIV can be co-administered with inactivated vaccines without issue, according to ACIP recommendations, as there is no significant interference between the two vaccine types.
The exclusion of pregnant persons reflects CBIC's emphasis on tailoring infection prevention strategies, including vaccination programs, to protect vulnerable populations while minimizing risks (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This decision is based on precautionary principles outlined in CDC and ACIP guidelines to ensure maternal and fetal safety (CDC Prevention and Control of Seasonal Influenza with Vaccines, 2023).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.1 - Collaborate with organizational leaders, 3.2 - Implement measures to prevent transmission of infectious agents. CDC Prevention and Control of Seasonal Influenza with Vaccines, 2023. CDC Immunization Schedules, 2024.


NEW QUESTION # 143
A patient with shortness of breath and a history of a tuberculin skin test (TST) of 15 mm induration was admitted to a semi-private room. The infection preventionist's FIRST action should be to

  • A. review the patient's medical record to determine the likelihood of pulmonary tuberculosis (TB).
  • B. report the findings to the Employee Health Department to initiate exposure follow-up of hospital staff.
  • C. transfer the patient to an airborne infection isolation room and initiate appropriate isolation for tuberculosis (TB).
  • D. contact the roommate's physician to initiate TST.

Answer: A

Explanation:
Before initiating airborne precautions, the infection preventionist must first confirm the clinical suspicion of active TB.
Step-by-Step Justification:
* Confirming Active TB:
* A positive tuberculin skin test (TST) alone does not indicate active disease.
* A review of chest X-ray, symptoms, and risk factors is needed.
* Medical Record Review:
* Past TB history, imaging, and sputum testing are key to diagnosis.
* Not all TST-positive patients require isolation.
Why Other Options Are Incorrect:
* A. Contact the roommate's physician to initiate TST: Premature, as no confirmation of active TB exists yet.
* C. Report findings to Employee Health for staff follow-up: Should occur only after TB confirmation.
* D. Transfer to airborne isolation immediately: Airborne isolation is necessary only if active TB is suspected based on clinical findings.
CBIC Infection Control References:


NEW QUESTION # 144
There are four cases of ventilator-associated pneumonia in a surgical intensive care unit with a total of 200 ventilator days and a census of 12 patients. Which of the following BEST expresses how this should be reported?

  • A. More information is needed regarding ventilator days per patient
  • B. Postoperative pneumonia rate of 6% in SICU patients
  • C. Ventilator-associated pneumonia rate of 2%
  • D. 20 ventilator-associated pneumonia cases/1000 ventilator days

Answer: D

Explanation:
The standard way to reportventilator-associated pneumonia (VAP) ratesis:
A white paper with black text AI-generated content may be incorrect.

Why the Other Options Are Incorrect?
* A. Ventilator-associated pneumonia rate of 2%- This does not use thecorrect denominator (ventilator days).
* C. Postoperative pneumonia rate of 6% in SICU patients-Not relevant, as the data focuses onVAP, not postoperative pneumonia.
* D. More information is needed regarding ventilator days per patient-The total ventilator days are already provided, so no additional data is required.
CBIC Infection Control Reference
APIC and NHSN recommend reporting VAP rates as cases per 1,000 ventilator days.


NEW QUESTION # 145
When conducting a literature search which of the following study designs may provide the best evidence of a direct causal relationship between the experimental factor and the outcome?

  • A. A descriptive study
  • B. A randomized-controlled trial
  • C. A case report
  • D. A case control study

Answer: B

Explanation:
To determine the best study design for providing evidence of a direct causal relationship between an experimental factor and an outcome, it is essential to understand the strengths and limitations of each study design listed. The goal is to identify a design that minimizes bias, controls for confounding variables, and establishes a clear cause-and-effect relationship.
* A. A case report: A case report is a detailed description of a single patient or a small group of patients with a particular condition or outcome, often including the experimental factor of interest. While case reports can generate hypotheses and highlight rare occurrences, they lack a control group and are highly susceptible to bias. They do not provide evidence of causality because they are observational and anecdotal in nature. This makes them the weakest design for establishing a direct causal relationship.
* B. A descriptive study: Descriptive studies, such as cross-sectional or cohort studies, describe the characteristics or outcomes of a population without manipulating variables. These studies can identify associations between an experimental factor and an outcome, but they do not establish causality due to the absence of randomization or control over confounding variables. For example, a descriptive study might show that a certain infectionrate is higher in a group exposed to a specific factor, but it cannot prove the factor caused the infection without further evidence.
* C. A case control study: A case control study compares individuals with a specific outcome (cases) to those without (controls) to identify factors that may contribute to the outcome. This retrospective design is useful for studying rare diseases or outcomes and can suggest associations. However, it is prone to recall bias and confounding, and it cannot definitively prove causation because the exposure is not controlled or randomized. It is stronger than case reports or descriptive studies but still falls short of establishing direct causality.
* D. A randomized-controlled trial (RCT): An RCT is considered the gold standard for establishing causality in medical and scientific research. In an RCT, participants are randomly assigned to either an experimental group (exposed to the factor) or a control group (not exposed or given a placebo).
Randomization minimizes selection bias and confounding variables, while the controlled environment allows researchers to isolate the effect of the experimental factor on the outcome. The ability to compare outcomes between groups under controlled conditions provides the strongest evidence of a direct causal relationship. This aligns with the principles of evidence-based practice, which the CBIC (Certification Board of Infection Control and Epidemiology) emphasizes for infection prevention and control strategies.
Based on this analysis, the randomized-controlled trial (D) is the study design that provides the best evidence of a direct causal relationship. This conclusion is consistent with the CBIC's focus on high-quality evidence to inform infection control practices, as RCTs are prioritized in the hierarchy of evidence for establishing cause- and-effect relationships.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated guidelines, 2023), which emphasizes the use of high-quality evidence, including RCTs, for validating infection control interventions.
CBIC Examination Content Outline, Domain I: Identification of Infectious Disease Processes, which underscores the importance of evidence-based study designs in infection control research.


NEW QUESTION # 146
The sensitivity of a laboratory test is the proportion of persons:

  • A. Without the disease who have a negative test.
  • B. With the disease who have a positive test.
  • C. With the disease who have a negative test.
  • D. Without the disease who have a positive test.

Answer: B

Explanation:
Sensitivity describes how well a test correctly identifies people who truly have the disease. It is the proportion of true positives among all people with the disease-i.e., the probability that the test will be positive when the disease is present. CDC training materials describe sensitivity as the ability of a test to correctly identify the presence of disease and connect it to true positives and false negatives, with the standard formula: Sensitivity = TP / (TP + FN).
Therefore, the correct definition is "with the disease who have a positive test" (Option A). Option B describes false negatives (people who have disease but test negative). Option C describes false positives (people without disease who test positive). Option D corresponds to specificity, which is the proportion of people without the disease who test negative (TN / [TN + FP]).
In infection prevention and control, understanding sensitivity is essential when selecting and interpreting screening or diagnostic tests (e.g., for outbreak investigations or surveillance), because low sensitivity increases missed cases (false negatives), potentially allowing ongoing transmission if cases are not recognized promptly.


NEW QUESTION # 147
During the past week, three out of four blood cultures from a febrile neonate in an intensive care unit grew coagulase-negative staphylococci. This MOST likely indicates:

  • A. Laboratory error.
  • B. Contamination.
  • C. Colonization.
  • D. Infection.

Answer: B

Explanation:
The scenario involves a febrile neonate in an intensive care unit (ICU) with three out of four blood cultures growing coagulase-negative staphylococci (CoNS) over the past week. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes accurate interpretation of microbiological data in the
"Identification of Infectious Disease Processes" domain, aligning with the Centers for Disease Control and Prevention (CDC) guidelines for healthcare-associated infections. Determining whether this represents a true infection, contamination, colonization, or laboratory error requires evaluating the clinical and microbiological context.
Option B, "Contamination," is the most likely indication. Coagulase-negative staphylococci, such as Staphylococcus epidermidis, are common skin flora and frequent contaminants in blood cultures, especially in neonates where skin preparation or sampling technique may be challenging. The CDC's "Guidelines for the Prevention of Intravascular Catheter-Related Infections" (2017) and the Clinical and Laboratory Standards Institute (CLSI) note that multiple positive cultures (e.g., two or more) are typically required to confirm true bacteremia, particularly with CoNS, unless accompanied by clear clinical signs of infection (e.g., worsening fever, hemodynamic instability) and no other explanation. The inconsistency (three out of four cultures) and the neonate's ICU setting-where contamination from skin or catheter hubs is common-suggest that the positive cultures likely result from contamination during blood draw rather than true infection. Studies, such as those in the Journal of Clinical Microbiology (e.g., Beekmann et al., 2005), indicate that CoNS in blood cultures is contaminated in 70-80% of cases when not supported by robust clinical correlation.
Option A, "Laboratory error," is possible but less likely as the primary explanation. Laboratory errors (e.g., mislabeling or processing mistakes) could occur, but the repeated growth in three of four cultures suggests a consistent finding rather than a random error, making contamination a more plausible cause. Option C,
"Colonization," refers to the presence of microorganisms on or in the body without invasion or immune response. While CoNS can colonize the skin or catheter sites, colonization does not typically result in positive blood cultures unless there is an invasive process, which is not supported by the data here. Option D,
"Infection," is the least likely without additional evidence. True CoNS bloodstream infections (e.g., catheter- related) in neonates are serious but require consistent positive cultures, clinical deterioration (e.g., persistent fever, leukocytosis), and often imaging or catheter removal confirmation. The febrile state alone, with inconsistent culture results, does not meet the CDC's criteria for diagnosing infection (e.g., at least two positive cultures from separate draws).
The CBIC Practice Analysis (2022) and CDC guidelines stress differentiating contamination from infection to avoid unnecessary treatment, which can drive antibiotic resistance. Given the high likelihood of contamination with CoNS in this context, Option B is the most accurate answer.
References:
* CBIC Practice Analysis, 2022.
* CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2017.
* Beekmann, S. E., et al. (2005). Coagulase-Negative Staphylococci in Blood Cultures. Journal of Clinical Microbiology.
* CLSI Guidelines on Blood Culture Interpretation, 2018.


NEW QUESTION # 148
In a long-term care facility, the classification of an infection as healthcare-associated implies the infection was:

  • A. Acquired in the facility.
  • B. Acquired within 24 hours of admission.
  • C. Identified in the facility.
  • D. Noted 72 hours after exposure.

Answer: A

Explanation:
An infection classified as healthcare-associated (HAI) means it is attributable to receiving care in a healthcare setting-in other words, it was acquired as a result of healthcare exposure rather than being present or incubating before care began. This concept applies across care settings, including long-term care facilities (LTCFs). The CDC describes HAIs as infections patients get while or soon after receiving health care, emphasizing acquisition linked to healthcare delivery rather than simply where the infection is detected.
The Association for Professionals in Infection Control and Epidemiology (APIC) similarly explains that HAIs are infections patients can get in a healthcare facility while receiving medical care, which aligns with the idea of being acquired in that setting.
Option B ("identified in the facility") is incorrect because an infection can be identified in an LTCF even if it was acquired elsewhere (e.g., incubating on admission or acquired during a recent hospitalization). Options A and D use fixed time thresholds; while some surveillance definitions use timing rules (often 48 hours in acute care) to help classify onset, "healthcare-associated" fundamentally implies acquisition related to healthcare exposure, best captured by acquired in the facility in this question


NEW QUESTION # 149
A nurse claims to have acquired hepatitis A virus infection as the result of occupational exposure. The source patient had an admitting diagnosis of viral hepatitis. Further investigation of this incident reveals a 5-day interval between exposure and onset of symptoms in the nurse. The patient has immunoglobulin G antibodies to hepatitis A. From the evidence, the infection preventionist may correctly conclude which of the following?

  • A. The evidence at this time fails to support the nurse's claim.
  • B. The patient has serologic evidence of recent hepatitis A viral infection.
  • C. The nurse should be given hepatitis A virus immunoglobulin.
  • D. The 5-day incubation period is consistent with hepatitis A virus transmission.

Answer: A

Explanation:
The infection preventionist's (IP) best conclusion, based on the provided evidence, is that the evidence at this time fails to support the nurse's claim of acquiring hepatitis A virus (HAV) infection through occupational exposure. This conclusion is grounded in the clinical and epidemiological understanding of HAV, as aligned with the Certification Board of Infection Control and Epidemiology (CBIC) guidelines. Hepatitis A typically has an incubation period ranging from 15 to 50 days, with an average of approximately 28-30 days, following exposure to the virus (CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.3 - Apply principles of epidemiology). The reported 5-day interval between exposure and symptom onset in the nurse is significantly shorter than the expected incubation period, making it inconsistent with HAV transmission. Additionally, the presence of immunoglobulin G (IgG) antibodies in the source patient indicates past exposure or immunity to HAV, rather than an active or recent infection, which would typically be associated with immunoglobulin M (IgM) antibodies during the acute phase.
Option A (the nurse should be given hepatitis A virus immunoglobulin) is not supported because post- exposure prophylaxis with HAV immunoglobulin is recommended only within 14 days of exposure to a confirmed case with active infection, and the evidence here does not confirm a recent exposure or active case.
Option C (the patient has serologic evidence of recent hepatitis A viral infection) is incorrect because IgG antibodies signify past infection or immunity, not a recent infection, which would require IgM antibodies.
Option D (the 5-day incubation period is consistent with hepatitis A virus transmission) is inaccurate due to the mismatch with the known incubation period of HAV.
The IP's role includes critically evaluating epidemiological data to determine the likelihood of transmission events. The discrepancy in the incubation period and the serologic status of the patient suggest that the nurse's claim may not be substantiated by the current evidence, necessitating further investigation rather than immediate intervention or acceptance of the claim. This aligns with CBIC's emphasis on accurate identification and investigation of infectious disease processes (CBIC Practice Analysis, 2022, Domain I:
Identification of Infectious Disease Processes, Competency 1.2 - Investigate suspected outbreaks or exposures).
References: CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competencies 1.2 - Investigate suspected outbreaks or exposures, 1.3 - Apply principles of epidemiology.


NEW QUESTION # 150
Following recent renovations on an oncology unit, three patients were identified with Aspergillus infections.
The infections were thought to be facility-acquired. Appropriate environmental microbiological monitoring would be to culture the:

  • A. Aerators
  • B. Air
  • C. Carpet
  • D. Ice

Answer: B

Explanation:
The scenario describes an outbreak of Aspergillus infections among three patients on an oncology unit following recent renovations, with the infections suspected to be facility-acquired. Aspergillus is a mold commonly associated with environmental sources, particularly airborne spores, and its presence in immunocompromised patients (e.g., oncology patients) poses a significant risk. The infection preventionist must identify the appropriate environmental microbiological monitoring strategy, guided by the Certification Board of Infection Control and Epidemiology (CBIC) and CDC recommendations. Let's evaluate each option:
* A. Air: Aspergillus species are ubiquitous molds that thrive in soil, decaying vegetation, and construction dust, and they are primarily transmitted via airborne spores. Renovations can disturb these spores, leading to aerosolization and inhalation by vulnerable patients. Culturing the air using methods such as settle plates, air samplers, or high-efficiency particulate air (HEPA) filtration monitoring is a standard practice to detect Aspergillusduring construction or post-renovation in healthcare settings, especially oncology units where patients are at high risk for invasive aspergillosis. This aligns with CBIC's emphasis on environmental monitoring for airborne pathogens, making it the most appropriate choice.
* B. Ice: Ice can be a source of contamination with bacteria (e.g., Pseudomonas, Legionella) or other pathogens if improperly handled or stored, but it is not a typical reservoir for Aspergillus, which is a mold requiring organic material and moisture for growth. While ice safety is important in infection control, culturing ice is irrelevant to an Aspergillus outbreak linked to renovations and is not a priority in this context.
* C. Carpet: Carpets can harbor dust, mold, and other microorganisms, especially in high-traffic or poorly maintained areas. Aspergillus spores could theoretically settle in carpet during renovations, but carpets are not a primary source of airborne transmission unless disturbed (e.g., vacuuming). Culturing carpet might be a secondary step if air sampling indicates widespread contamination, but it is less direct and less commonly recommended as the initial monitoring site compared to air sampling.
* D. Aerators: Aerators (e.g., faucet aerators) can harbor waterborne pathogens like Pseudomonas or Legionella due to biofilm formation, but Aspergillus is not typically associated with water systems unless there is significant organic contamination or aerosolization from water sources (e.g., cooling towers). Culturing aerators is relevant for waterborne outbreaks, not for an Aspergillus outbreak linked to renovations, making this option inappropriate.
The best answer is A, culturing the air, as Aspergillus is an airborne pathogen, and renovations are a known risk factor for spore dispersal in healthcare settings. This monitoring strategy allows the infection preventionist to confirm the source, assess the extent of contamination, and implement control measures (e.g., enhanced filtration, construction barriers) to protect patients. This is consistent with CBIC and CDC guidelines for managing fungal outbreaks in high-risk units.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV:
Environment of Care, which recommends air sampling for Aspergillus during construction-related outbreaks.
CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes environmental monitoring for facility-acquired infections.
CDC Guidelines for Environmental Infection Control in Healthcare Facilities (2022), which advocate air culturing to detect Aspergillus post-renovation in immunocompromised patient areas.


NEW QUESTION # 151
A Quality Improvement Committee is trying to decrease catheter-associated urinary tract infections (CAUTIs) in the hospital. Which of the following would be an outcome measure that would help to show a reduction in CAUTIs?

  • A. Percentage of patients with indwelling urinary catheters
  • B. Rate of CAUTI per 1000 indwelling urinary catheter days
  • C. Rate of patients receiving daily indwelling urinary catheter care
  • D. Percentage of staff trained to insert indwelling urinary catheters

Answer: B

Explanation:
Anoutcome measuretracks the end result of healthcare processes. TheCAUTI rate per 1,000 catheter days directly measures the frequency of infections, making it an ideal outcome metric.
* From theAPIC Text:
"An incidence rate (i.e., the number of new cases during a time period, such as the rate of patients with urinary catheters who get a CAUTI) is a frequently used outcome performance measure."
* Other choices like care compliance or training areprocess measures, not outcomes.
References:
APIC Text, 4th Edition, Chapter 17 - Performance Measures


NEW QUESTION # 152
Which of the following statements characterizes the proper use of chemical disinfectants?

  • A. The label on the solution being used must indicate that it kills all viable micro-organisms.
  • B. The solution should be adaptable for use as an antiseptic.
  • C. All items to be processed must be cleaned prior to being submerged in solution.
  • D. A chemical indicator must be used with items undergoing high-level disinfection.

Answer: C

Explanation:
The proper use of chemical disinfectants is a critical aspect of infection control, as outlined by the Certification Board of Infection Control and Epidemiology (CBIC). Chemical disinfectants are used to eliminate or reduce pathogenic microorganisms on inanimate objects, and their effective application requires adherence to specific protocols to ensure safety and efficacy. Let's evaluate each option based on infection control standards:
* A. All items to be processed must be cleaned prior to being submerged in solution.: This statement is a fundamental principle of disinfectant use. Cleaning (e.g., removing organic material such as blood, tissue, or dirt) is a prerequisite before disinfection because organic matter can inactivate or reduce the effectiveness of chemical disinfectants. The CBIC emphasizes that proper cleaning is the first step in the disinfection process to ensure that disinfectants can reach and kill microorganisms. This step is universally required for all levels of disinfection (low, intermediate, and high), making it a characterizing feature of proper use.
* B. The label on the solution being used must indicate that it kills all viable micro-organisms.: This statement is misleading. No disinfectant can be guaranteed to kill 100% ofall viable microorganisms under all conditions, as efficacy depends on factors like contact time, concentration, and the presence of organic material. Disinfectant labels typically indicate the types of microorganisms (e.g., bacteria, viruses, fungi) and the level of disinfection (e.g., high-level, intermediate-level) they are effective against, based on standardized tests (e.g., EPA or FDA guidelines). Claiming that a solution kills all viable microorganisms is unrealistic and not a requirement for proper use; instead, the label must specify the intended use and efficacy, which varies by product.
* C. The solution should be adaptable for use as an antiseptic.: An antiseptic is a chemical agent used on living tissue (e.g., skin) to reduce microbial load, whereas a disinfectant is used on inanimate surfaces.
While some chemicals (e.g., alcohol) can serve both purposes, this is not a requirement for proper disinfectant use. The adaptability of a solution for antiseptic use is irrelevant to its classification or application as a disinfectant, which focuses on environmental or equipment decontamination. This statement does not characterize proper disinfectant use.
* D. A chemical indicator must be used with items undergoing high-level disinfection.: Chemical indicators (e.g., test strips or tapes) are used to verify that the disinfection process has met certain parameters (e.g., concentration or exposure time), particularly in sterilization or high-level disinfection (HLD). While this is a recommended practice for quality assurance in HLD (e.g., with glutaraldehyde or hydrogen peroxide), it is not a universal requirement for all chemical disinfectant use. HLD applies specifically to semi-critical items (e.g., endoscopes), and the need for indicators depends on the protocol and facility standards. This statement is too narrow and specific to characterize the proper use of chemical disinfectants broadly.
The correct answer is A, as cleaning prior to disinfection is a foundational and universally applicable step in the proper use of chemical disinfectants. This aligns with CBIC guidelines, which stress the importance of a clean surface to maximize disinfectant efficacy and prevent infection transmission in healthcare settings.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV:
Environment of Care, which mandates cleaning as a prerequisite for effective disinfection.
CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes protocols for the proper use of disinfectants, emphasizing pre-cleaning.
CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities (2021), which reinforce that cleaning must precede disinfection to ensure efficacy.


NEW QUESTION # 153
An infection preventionist (IP) is informed of a measles outbreak in a nearby community. What is the IP's FIRST priority when working with Occupational Health?

  • A. Isolate employees who have recently traveled to areas with measles outbreaks.
  • B. Set up a mandatory vaccination clinic in collaboration with Occupational Health and local public health partners.
  • C. Reassign employees who are pregnant from caring for patients with suspected measles.
  • D. Verify that employees in high-risk exposure areas of the facility have adequate immunity to measles.

Answer: D

Explanation:
When an infection preventionist (IP) is informed of a measles outbreak in a nearby community, the immediate priority is to protect healthcare workers and patients from potential exposure, particularly in a healthcare setting where vulnerable populations are present. Working with Occupational Health, the IP must follow a structured approach to mitigate the risk of transmission, guided by principles from the Certification Board of Infection Control and Epidemiology (CBIC) and public health guidelines. Let's evaluate each option to determine the first priority:
A). Isolate employees who have recently traveled to areas with measles outbreaks: Isolating employees who may have been exposed to measles during travel is an important infection control measure to prevent transmission within the facility. However, this action assumes that exposure has already occurred and requires identification of affected employees first. Without knowing the immunity status of the workforce, this step is reactive rather than preventive and cannot be the first priority.
B). Reassign employees who are pregnant from caring for patients with suspected measles: Reassigning pregnant employees is a protective measure due to the severe risks measles poses to fetuses (e.g., congenital rubella syndrome risks, though measles itself is more about maternal complications). This action is specific to a subset of employees and depends on identifying patients with suspected measles, which may not yet be confirmed. It is a secondary step that follows assessing overall immunity and exposure risks, making it inappropriate as the first priority.
C). Verify that employees in high-risk exposure areas of the facility have adequate immunity to measles:
Verifying immunity is the foundational step in preventing measles transmission in a healthcare setting.
Measles is highly contagious, and healthcare workers in high-risk areas (e.g., emergency departments, pediatric wards) are at increased risk of exposure. The CBIC and CDC recommend ensuring that all healthcare personnel have documented evidence of measles immunity (e.g., two doses of MMR vaccine, laboratory evidence of immunity, or prior infection) as a primary infection control strategy during outbreaks.
This step allows the IP to identify vulnerable employees, implement targeted interventions, and comply with occupational health regulations. It is the most proactive and immediate priority when an outbreak is reported in the community.
D). Set up a mandatory vaccination clinic in collaboration with Occupational Health and local public health partners: Establishing a vaccination clinic is a critical long-term strategy to increase immunity and control the outbreak. However, this requires planning, resource allocation, and coordination, which take time. It is a subsequent step that follows verifying immunity status to identify those who need vaccination. While important, it cannot be the first priority due to its logistical demands.
The first priority is C, as verifying immunity among employees in high-risk areas establishes a baseline to prevent transmission before reactive measures (e.g., isolation, reassignment) or broader interventions (e.g., vaccination clinics) are implemented. This aligns with CBIC's focus on proactive risk assessment and occupational health safety during infectious disease outbreaks, ensuring a rapid response to protect the healthcare workforce and patients.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which prioritizes immunity verification during outbreaks.
CBIC Examination Content Outline, Domain IV: Environment of Care, which includes ensuring employee immunity as part of outbreak preparedness.
CDC Guidelines for Measles Prevention (2023), which recommend verifying healthcare worker immunity as the initial step during a measles outbreak.


NEW QUESTION # 154
A surgeon is beginning a new procedure in the facility within the next two weeks and requires loaner instruments. Infection prevention processes should ensure that

  • A. items arrive in time for immediate use steam sterilization.
  • B. instruments are able to be used prior to the biological indicator results.
  • C. the planning process takes place after the instruments have arrived.
  • D. staff education related to loaner instrument reprocessing has occurred.

Answer: D

Explanation:
The correct answer is D, "staff education related to loaner instrument reprocessing has occurred," as this is the infection prevention process that should be ensured when a surgeon is beginning a new procedure requiring loaner instruments within the next two weeks. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, loaner instruments-those borrowed from external sources for temporary use-pose unique infection prevention challenges due to potential variability in reprocessing standards and unfamiliarity among staff. Ensuring that staff are educated on proper reprocessing protocols (e.g., cleaning, sterilization, and handling per manufacturer instructions and AAMI ST79) is critical to prevent healthcare- associated infections (HAIs) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This education should cover the specific requirements for loaner instruments, including documentation and verification of sterilization, and should occur proactively before the instruments are used to ensure competency and compliance.
Option A (items arrive in time for immediate use steam sterilization) is a logistical consideration, but it does not address the infection prevention process itself; timely arrival is necessary but insufficient without proper reprocessing validation. Option B (instruments are able to be used prior to the biological indicator results) is unsafe, as biological indicators are essential to confirm sterilization efficacy, and using instruments before results are available violates infection control standards. Option C (the planning process takes place after the instruments have arrived) is impractical, as planning (e.g., coordinating with vendors, assessing reprocessing needs) must occur in advance to ensure readiness and safety, not as a reactive step.
The focus on staff education aligns with CBIC's emphasis on preparing healthcare personnel to handle loaner instruments safely, reducing the risk of contamination and ensuring patient safety (CBIC Practice Analysis,
2022, Domain IV: Education and Research, Competency 4.1 - Develop and implement educational programs).
This proactive measure is supported by AAMI and CDC guidelines, which stress the importance of training for reprocessing complex or unfamiliar devices.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment; Domain IV: Education and Research, Competency 4.1 - Develop and implement educational programs. AAMI ST79:2017, Comprehensive guide to steam sterilization and sterility assurance in health care facilities.


NEW QUESTION # 155
Following recent renovations on an oncology unit, three patients were identified with Aspergillus infections.
The infections were thought to be facility-acquired. Appropriate environmental microbiological monitoring would be to culture the:

  • A. Aerators
  • B. Air
  • C. Carpet
  • D. Ice

Answer: B

Explanation:
The scenario describes an outbreak of Aspergillus infections among three patients on an oncology unit following recent renovations, with the infections suspected to be facility-acquired. Aspergillus is a mold commonly associated with environmental sources, particularly airborne spores, and its presence in immunocompromised patients (e.g., oncology patients) poses a significant risk. The infection preventionist must identify the appropriate environmental microbiological monitoring strategy, guided by the Certification Board of Infection Control and Epidemiology (CBIC) and CDC recommendations. Let's evaluate each option:
* A. Air: Aspergillus species are ubiquitous molds that thrive in soil, decaying vegetation, and construction dust, and they are primarily transmitted via airborne spores. Renovations can disturb these spores, leading to aerosolization and inhalation by vulnerable patients. Culturing the air using methods such as settle plates, air samplers, or high-efficiency particulate air (HEPA) filtration monitoring is a standard practice to detect Aspergillus during construction or post-renovation in healthcare settings, especially oncology units where patients are at high risk for invasive aspergillosis. This aligns with CBIC's emphasis on environmental monitoring for airborne pathogens, making it the most appropriate choice.
* B. Ice: Ice can be a source of contamination with bacteria (e.g., Pseudomonas, Legionella) or other pathogens if improperly handled or stored, but it is not a typical reservoir for Aspergillus, which is a mold requiring organic material and moisture for growth. While ice safety is important in infection control, culturing ice is irrelevant to an Aspergillus outbreak linked to renovations and is not a priority in this context.
* C. Carpet: Carpets can harbor dust, mold, and other microorganisms, especially in high-traffic or poorly maintained areas. Aspergillus spores could theoretically settle in carpet during renovations, but carpets are not a primary source of airborne transmission unless disturbed (e.g., vacuuming). Culturing carpet might be a secondary step if air sampling indicates widespread contamination, but it is less direct and less commonly recommended as the initial monitoring site compared to air sampling.
* D. Aerators: Aerators (e.g., faucet aerators) can harbor waterborne pathogens like Pseudomonas or Legionella due to biofilm formation, but Aspergillus is not typically associated with water systems unless there is significant organic contamination or aerosolization from water sources (e.g., cooling towers). Culturing aerators is relevant for waterborne outbreaks, not for an Aspergillus outbreak linked to renovations, making this option inappropriate.
The best answer is A, culturing the air, as Aspergillus is an airborne pathogen, and renovations are a known risk factor for spore dispersal in healthcare settings. This monitoring strategy allows the infection preventionist to confirm the source, assess the extent of contamination, and implement control measures (e.g., enhanced filtration, construction barriers) to protect patients. This is consistent with CBIC and CDC guidelines for managing fungal outbreaks in high-risk units.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV:
Environment of Care, which recommends air sampling for Aspergillus during construction-related outbreaks.
CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes environmental monitoring for facility-acquired infections.
CDC Guidelines for Environmental Infection Control in Healthcare Facilities (2022), which advocate air culturing to detect Aspergillus post-renovation in immunocompromised patient areas.


NEW QUESTION # 156
......

Fully Updated Dumps PDF - Latest CIC Exam Questions and Answers: https://realpdf.free4torrent.com/CIC-valid-dumps-torrent.html